Showing results (1-10 of 425) with videos related to
Sort By:
Pageof 43
Revue Medicale De Liege|March 30, 2010
[Chronic graft-versus-host disease: a multidisciplinary approach]S Servais, E Willems, Y Beguin, et al.Revue Medicale De Liege|March 1, 2013
[Allogeneic hematopoietic stem cell transplantation: what is the upper age limit?]S Servais, E Willems, Y Beguin, et al.Revue Medicale De Liege|June 3, 2021
[Allogeneic hematopoietic stem cell transplantation : general principles and recent progress]J Narinx, S Servais, F Baron, et al.Revue Medicale De Liege|June 3, 2022
[Acute and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]A Barzin, C Geurten, E Willems, et al.Revue Medicale De Liege|June 3, 2021
[Diffuse large B-cell lymphoma: a revolutionary treatment based on genetically-modified immune cells called CAR T cells]C Maquet, Y Beguin, B De Prijck, et al.Revue Medicale Suisse|October 5, 2005
[Nonmyeloablative stem cell transplantation as cancer immunotherapy]E Willems, F Baron, G Vanstraelen, et al.Bone Marrow Transplantation|September 1, 2009
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioningE Willems, F Baron, L Seidel, et al.Revue Medicale De Liege|August 30, 2007
[Current therapies in hematology]B De Prijck, F Baron, Y Beguin, et al.Bone Marrow Transplantation|January 12, 2010
Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioningE Willems, S Humblet-Baron, O Dengis, et al.Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Nonmyeloablative allogeneic hematopoietic stem cell transplantationF Baron, Y BeguinPageof 43